(Press-News.org) Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term. Researchers at Amsterdam UMC investigated whether this dysregulation can be prevented by starting HIV medication immediately after infection – i.e. within a few days. They saw that six months after this early treatment, the immune system did indeed work as in people without HIV. But in the longer term, the immune system was disrupted again. This is shown by research by Amsterdam UMC, published in the journal EBioMedicine.
Early treatment protects immune systems only temporarily
For this study, the scientists examined the immune system of men with HIV who started taking HIV medication immediately after infection (acute HIV infection) and compared it with people who started taking HIV medication later – in the chronic phase. The immune system was also compared with that of people without HIV. The researchers mainly looked at the role of certain immune cells, so-called monocytes, which are important for the initial defence against viruses.
The research shows that people who start taking HIV medication in the acute phase still have a well-functioning immune system in the beginning. This immune response is similar to that of people without HIV. But three years after the start of treatment, the immune cells have become dysfunctional, blood tests show. The cells then no longer react as they do in healthy people: the production of important pro-inflammatory proteins decreases.
Important discovery for HIV care and research
This finding is striking, because until now it was thought that starting HIV inhibitors very early actually prevents permanent damage to the immune system. However, the current results show that this advantage is only temporary. Godelieve de Bree, internist-infectiologist at Amsterdam UMC: "Our research shows that after an acute HIV infection, there is a limited period in which the immune system still responds normally, but that this protection disappears over the years, even with successful treatment. This makes it clear that in HIV infection and treatment, it is important to continue to look for ways to protect the immune system in a truly sustainable way."
Theo Geijtenbeek, professor of immunology at Amsterdam UMC, also emphasizes the importance of this discovery: "This is really new. Our results show that early treatment does provide temporary benefit, but that after a few years dysregulation still occurs in the immune system. Our results show that the so-called 'window of opportunity' in which the immune system responds well is probably only in the first months after infection."
Impact for treatment and follow-up research
This requires new treatment systems that also protect the immune system in the longer term. Further research must show why this happens, and how this disruption can be prevented. "These insights are relevant for future HIV treatment," says de Bree. "We must focus on better protection of the immune system, even after the first period."
END
Temporary benefit for immune system in early HIV treatment, but dysregulation returns
2025-11-08
ELSE PRESS RELEASES FROM THIS DATE:
Chronic kidney disease is now the ninth leading cause of death
2025-11-08
Record numbers of men and women globally are now estimated to have reduced kidney function, a new study shows. Figures rose from 378 million people with the disease in 1990 to 788 million in 2023 as the world population grew and aged, making it for the first time a top 10 cause of death worldwide.
Led by researchers at NYU Langone Health, the University of Glasgow, and the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, the analysis explored the rise of the illness, in which the kidneys gradually lose their ability to filter waste and excess fluid from the blood. Mild cases may have no symptoms while the most severe stages ...
Chronic kidney disease has more than doubled since 1990, now affecting nearly 800 million people worldwide
2025-11-08
In 2023, chronic kidney disease (CKD) was the 9th-leading cause of death worldwide, responsible for nearly 1.5 million deaths.
Unlike most other leading causes of death, CKD mortality rates continue to rise, signaling a growing global health crisis.
In 2023, CKD ranked as the 12th-leading cause of disability worldwide and the 7th-leading driver of cardiovascular deaths. Kidney dysfunction alone accounted for almost 12% of all global cardiovascular deaths.
Diabetes, obesity, and high blood pressure remain the top drivers of CKD, alongside dietary risks and environmental factors.
SEATTLE, Wash. – Nov. 7, ...
Participant experiences in a kidney failure care intervention in the navigate-kidney study
2025-11-08
About The Study: The results of this study suggest that community health workers played a vital role in improving patient engagement, emotional wellbeing, and self-efficacy, suggesting their integration into dialysis care teams may enhance holistic, patient-centered care.
Corresponding Author: To contact the corresponding author, Lilia Cervantes, MD, email Lilia.Cervantes@cuanschutz.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.48506)
Editor’s ...
Community health worker support for Hispanic and Latino individuals receiving hemodialysis
2025-11-08
About The Study: In this randomized clinical trial, a culturally tailored community health worker intervention modestly lowered interdialytic weight gain and improved dialysis adherence and patient activation among Hispanic and Latino patients with hemodialysis-dependent kidney failure.
Corresponding Author: To contact the corresponding author, Lilia Cervantes, MD, MSc, email lilia.cervantes@cuanschutz.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamainternmed.2025.5305)
Editor’s Note: Please see the article for additional information, including other authors, author ...
Scientists unveil new strategies to balance farming and ecological protection in Northeast China
2025-11-07
As China’s most important grain-producing region, Northeast China plays a vital role in safeguarding national food security. Yet this agricultural powerhouse faces a growing dilemma: how to maintain high crop yields while protecting the fragile ecosystems that sustain long-term productivity. A new study published in Agricultural Ecology and Environment identifies the key conflicts between agricultural expansion and ecological protection in the region and proposes integrated strategies to achieve a more sustainable balance.
Over the past four decades, Northeast China’s farmlands ...
UT Health San Antonio scientist helps shape new traumatic brain injury guidelines
2025-11-07
SAN ANTONIO, Nov. 7, 2025 – Traumatic brain injury, or TBI, affects millions of Americans each year, often resulting in long-term health challenges. New national recommendations are now paving the way for more effective short- and long-term care for patients with TBI.
Monica Verduzco-Gutierrez, MD, a physiatrist with UT Health San Antonio, the academic health center of The University of Texas at San Antonio, and professor and chair of the Department of Physical Medicine and Rehabilitation at UT San Antonio’s Long School of Medicine, served on the National Academies of Sciences, ...
Rising nitrogen and rainfall could supercharge greenhouse gas emissions from the world’s largest grasslands
2025-11-07
As the planet warms and rainfall patterns shift, new research suggests that the world’s largest grassland region may become a growing source of nitrous oxide, a greenhouse gas nearly 300 times more potent than carbon dioxide.
A team of scientists led by Dr. Shuping Qin from the Chinese Academy of Sciences examined how soil and climate conditions control the process of denitrification, a key microbial pathway that converts nitrogen compounds in soil into gases including nitrous oxide (N₂O) and nitrogen gas (N₂). Their study, recently published in Environmental and Biogeochemical Processes, is the first to map how denitrification responds ...
Study uncovers glomerular disease outcomes across the lifespan
2025-11-07
Houston, TX (November 7, 2025) — New research reveals that contrary toconventional belief, primary glomerular diseases are not necessarily benign for children and young adults. In fact, some subsets of children and young adults may experience faster kidney function decline than older patients. The findings will be presented at ASN Kidney Week 2025 November 5–9.
Direct comparisons of outcomes between adult and pediatric patients with primary glomerular diseases are rare—including minimal change disease (MCD), focalsegmental ...
Sotagliflozin outperforms dapagliflozin for reducing salt- sensitive hypertension and kidney injury in rats
2025-11-07
Houston, TX (November 7, 2025) — Sodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed to treat type 2 diabetes, have significant heart- and kidney- protective effects. In the kidney, SGLT2 reabsorbs approximately 97% offiltered glucose in the S1 and S2 segments of the proximal tubule, while SGLT1reabsorbs the remainder in the S3 segment. In research conducted in rats, investigators found that dual inhibition of SGLT1 and SGLT2 more effectively reduces salt-sensitive hypertension and kidney injury than SGLT2 inhibition alone. The findings will be presented ...
Trial analysis reveals almost all adults with hypertensive chronic kidney disease would benefit from intensive blood pressure lowering
2025-11-07
Houston, TX (November 7, 2025) — An analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) indicates that nearly all adults with chronic kidney disease (CKD) would have benefits that outweigh the harm from a systolic blood pressure target of <120 mm Hg compared with a target of <140 mm Hg. Thefindings will be presented at ASN Kidney Week 2025 November 5– 9.
In a benefit-harm trade-off analysis of 2,012 participants with CKD, investigators found that when predicting individualized treatment effects for multiple outcomesand simulating ...